Clinical trial: An open-label, randomised trial of different re-start strategies after treatment withdrawal in HBeAg negative chronic hepatitis B.

Autor: Johannessen A; Department of Infectious Diseases, Vestfold Hospital Trust, Tønsberg, Norway.; Department of Infectious Diseases, Regional Advisory Unit for Imported and Tropical Diseases, Oslo University Hospital, Oslo, Norway.; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Reikvam DH; Department of Infectious Diseases, Regional Advisory Unit for Imported and Tropical Diseases, Oslo University Hospital, Oslo, Norway.; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Aleman S; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden., Berhe N; Department of Infectious Diseases, Vestfold Hospital Trust, Tønsberg, Norway.; Department of Infectious Diseases, Regional Advisory Unit for Imported and Tropical Diseases, Oslo University Hospital, Oslo, Norway.; Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia., Weis N; Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Hvidovre, Denmark.; Faculty of Health and Medical Sciences, Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Desalegn H; Department of Infectious Diseases, Vestfold Hospital Trust, Tønsberg, Norway.; Medical Department, St. Paul's Hospital Millennium Medical College, Addis Ababa, Ethiopia., Stenstad T; Department of Infectious Diseases, Vestfold Hospital Trust, Tønsberg, Norway., Heggelund L; Vestre Viken Hospital Trust, Drammen Hospital, Drammen, Norway., Samuelsen E; Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway., Karlsen LN; Department of Gastroenterology, Stavanger University Hospital, Stavanger, Norway., Lindahl K; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden., Pettersen FO; Department of Infectious Diseases, Regional Advisory Unit for Imported and Tropical Diseases, Oslo University Hospital, Oslo, Norway., Iversen J; Department of Infectious Diseases, Regional Advisory Unit for Imported and Tropical Diseases, Oslo University Hospital, Oslo, Norway., Kleppa E; Department of Infectious Diseases, Regional Advisory Unit for Imported and Tropical Diseases, Oslo University Hospital, Oslo, Norway., Bollerup S; Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Hvidovre, Denmark., Winckelmann AA; Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Hvidovre, Denmark., Brugger-Synnes P; Department of Medicine, Ålesund Hospital, Ålesund, Norway., Simonsen HE; Department of Medicine, Bodø Hospital, Bodø, Norway., Svendsen J; Vestre Viken Hospital Trust, Bærum Hospital, Drammen, Norway., Kran AB; Norwegian Institute of Public Health, Oslo, Norway.; Department of Microbiology, Oslo University Hospital, Oslo, Norway., Holmberg M; Department of Infectious Diseases, Vestfold Hospital Trust, Tønsberg, Norway., Olsen IC; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.; Department of Research Support for Clinical Trials, Oslo University Hospital, Oslo, Norway., Rueegg CS; Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway., Dalgard O; Faculty of Medicine, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Department of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway.

Publikováno v: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2024 Aug; Vol. 60 (4), pp. 434-445. Date of Electronic Publication: 2024 Jul 05.

The overriding role of surgery and tumor grade for long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based cohort study.

Autor: Søreide JA; Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway., Kvaløy JT; Department of Research, Stavanger University Hospital, Stavanger, Norway.; Department of Mathematics and Physics, University of Stavanger, Stavanger, Norway., Lea D; Department of Clinical Medicine, University of Bergen, Bergen, Norway.; Department of Pathology, Stavanger University Hospital, Stavanger, Norway., Sandvik OM; Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway., Al-Saiddi M; Department of Radiology and Nuclear Medicine, Stavanger University Hospital, Stavanger, Norway., Haslerud TM; Department of Radiology and Nuclear Medicine, Stavanger University Hospital, Stavanger, Norway., Garresori H; Department of Oncology, Stavanger University Hospital, Stavanger, Norway., Karlsen LN; Department of Gastroenterology, Stavanger University Hospital, Stavanger, Norway., Gudlaugsson E; Department of Pathology, Stavanger University Hospital, Stavanger, Norway., Søreide K; Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway.; Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Publikováno v: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2022 Feb; Vol. 5 (2), pp. e1462. Date of Electronic Publication: 2021 Jun 08.

Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.

Autor: Syversen SW; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway., Goll GL; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway., Jørgensen KK; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway., Sandanger Ø; Section of Dermatology, Oslo University Hospital, Oslo, Norway., Sexton J; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway., Olsen IC; Department of Research Support for Clinical Trials, Oslo University Hospital, Oslo, Norway., Gehin JE; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway., Warren DJ; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Brun MK; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway., Klaasen RA; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Karlsen LN; Department of Gastroenterology, Stavanger University Hospital, Stavanger, Norway., Noraberg G; Department of Gastroenterology, Hospital of Southern Norway Trust, Arendal, Norway., Zettel C; Department of Rheumatology, Betanien Hospital, Skien, Norway., Ljoså MKA; Department of Rheumatology, Ålesund Hospital, Ålesund, Norway., Haugen AJ; Department of Rheumatology, Østfold Hospital Trust, Moss, Norway., Njålla RJ; Department of Rheumatology, Nordland Hospital Trust, Bodø, Norway., Bruun TJ; Department of Rheumatology, University Hospital of North Norway, Tromsø, Norway., Seeberg KA; Departement of Gastroenterology, Vestfold Hospital Trust, Tønsberg, Norway., Michelsen B; Division of Rheumatology, Department of Medicine, Hospital of Southern Norway Trust, Kristiansand, Norway., Strand EK; Lillehammer Hospital for Rheumatic Diseases, Lillehammer, Norway., Skorpe S; Haugesund Hospital for Rheumatic Diseases, Haugesund, Norway., Blomgren IM; Department of Gastroenterology, Fonna Hospital Trust, Haugesund, Norway., Bragnes YH; Department of Rheumatology, Vestre Viken Hospital Trust, Drammen, Norway., Dotterud CK; Department of Dermatology, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway., Thune T; Department of Dermatology, Haukeland University Hospital, Bergen, Norway., Ystrøm CM; Department of Medicine, Innlandet Hospital Trust, Elverum, Norway., Torp R; Department of Medicine, Innlandet Hospital Trust, Hamar, Norway., Mielnik P; Department of Neurology, Rheumatology, and Physical Medicine, Førde Hospital Trust, Førde, Norway., Mørk C; Akershus Dermatology Center, Lørenskog, Norway., Kvien TK; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway., Jahnsen J; Department of Gastroenterology, Akershus University Hospital, Lørenskog, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway., Bolstad N; Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway., Haavardsholm EA; Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway.

Publikováno v: JAMA [JAMA] 2021 May 04; Vol. 325 (17), pp. 1744-1754.

Palliative surgical outcome score (PSOS) in patients treated palliatively with self-expanding metal stent (SEMS) for malignant incurable colorectal obstruction.

Autor: Søreide JA; Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway. Electronic address: jonarne.soreide@uib.no., Tholfsen T; Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway., Karlsen LN; Department of Gastroenterology, Stavanger University Hospital, Stavanger, Norway., Kvaløy JT; Department of Research, Stavanger University Hospital, Stavanger, Norway; Department of Mathematics and Physics, University of Stavanger, Norway., Kørner H; Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway; Regional Centre of Palliative Medicine in Western Norway, Bergen, Norway; Department of Clinical Medicine, University of Bergen, Bergen, Norway.

Publikováno v: Surgical oncology [Surg Oncol] 2019 Jun; Vol. 29, pp. 134-139. Date of Electronic Publication: 2019 Apr 30.

Medical management of fistulising Crohn's disease.

Autor: Grimstad T, Carlsen A, Karlsen LN

Publikováno v: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke [Tidsskr Nor Laegeforen] 2019 Jan 09; Vol. 139 (1). Date of Electronic Publication: 2019 Jan 09 (Print Publication: 2019).